We are a R&D laboratory for
Real World Evidence,
Implementation Science,
Scientific Consulting
We are expert biomedical scientists, doctors, academics and engineers that are passionate about understanding diseases, injuries and improving the quality of healthcare systems. Our lab covers every aspect of the study lifecycle for Real World Evidence and Implementation Science, fostering truly collaborative and federated research with institutions across the globe.
Services
Our laboratory provides end-to-end services for Real World Evidence & Implementation Science from study development to result dissemination. We also provide expert medical and scientific consulting in key medical fields.
How we work
We conduct our work according to the highest standard of transparency, privacy and rigor.
Senior Management
We are passionate academics in biomedical science and medicine, with a proven professional track record in national and international institutions both in public and private sectors.
Teresa Magalhães MD PhD
Chairman and Chief Executive Officer
Teresa is a medical doctor and full professor at the Faculty of Medicine of the University of Porto (FMUP) with a PhD in social medicine and habilitation in medical sociology. She is a visiting professor in
multiple national and international
universities in medicine, law and
psychology. She has got the certification on Healthcare Units Management by the Portuguese Medical Association. Prior to co-founding MTG
she has served the board of directors
of the National Institute of Legal Medicine and Forensic Sciences of Portugal for more than a decade.
LinkedIn | ORCID
Isabel Taveira-Gomes MD
Board Member
Isabel Taveira-Gomes holds a Master degree in Medicine from the FMUP and is a specialist in child and adolescent psychiatry at ULS Matosinhos. Isabel has served as a Teaching Assistant for Medical Psychology for over a decade, and is currently conducting her PhD in measuring the impact of mindfulness programs in institutionalised adolescents.
LinkedIn | ORCID
Ricardo Dinis-Oliveira PharmD PhD
Board Member
Ricardo is an expert biomedical scientist with a PhD in Toxicology, ranked among the world's top 2% scientists. He is a full professor at IUCS-CESPU, with habilitation in various universities. Serves as an editor and member of the editorial board of various high-impact scientific journals. Prior to joining MTG he founded the Portuguesa Association of Forensic Sciences, of which he is the current president.
LinkedIn | ORCID
Tiago Taveira-Gomes MD ME MSc PhD
Executive Board Advisor
Tiago is a medical doctor, data
scientist and software architect. He is also an invited
professor in medicine, data science,
medical informatics, software
development and clinical research in various universities. He completed a PhD in medical informatics, a master in information engineering, a specialization in family medicine, and a post-graduation in health management. Before co-founding MTG he served as director of business unit and principal architect at ALERT Life Sciences Computing.
LinkedIn | ORCID
Eduardo Castro Marques MSc
Legal Board Advisor
Eduardo Castro Marques is a Founding Partner at Dower Law Firm, with a Law degree from the University of Porto and a Master's in Contract and Business Law from the University of Minho. He specializes in Administrative Legal Sciences and Corporate Law, with further education in Cybersecurity and EU Data Protection Compliance. Eduardo founded the Young Labor Lawyers Association (AJJ) and teaches Human Resources and Labor Relations as a lecturer at the Instituto Superior de Entre Douro and Vouga. He is also active in procedural practices education across multiple universities and a member of the Portuguese Bar Association's Institute of Law Firms.
LinkedIn
Team
We are a dedicated team of medical doctors, engineers, data scientists and academics on a mission to improve population health and sustainability of healthcare systems.
Advisors
We work closely with clinical experts to ensure our science is well aligned the current challenges in medicine and healthcare institutions.
Francisco Araújo
MD, Internal Medicine
Dr. Araújo is the director of internal medicine department at Lusíadas Lisbon Hospital, and president elect of the Portuguese Society of Atherosclerosis.
ORCID
Carla Santos-Araújo
MD PhD, Nephrology
Professor Santos-Araújo is the director of nephrology at Hospital Pedro Hispano and an invited professor at the physiology Department of the Faculty of Medicine University of Porto.
ORCID
Dulce Pinto
RN MSc MBA, Executive Management
Dr. Pinto is a nursing manager at Unidade Local de Saúde do Alto Minho, and has served as executive director and advisor of multiple healthcare institutions in Portugal.
LinkedIn
Certifications
We are recognized at national and international level to conduct R&D activities in Real World Evidence and Implementation Science.
Accredited CRO
Recognition by Portuguese Innovation Agency to conduct R&D under SIFIDE incentive program.
Certified SME
Certification for standardization of healthcare data according to the OMOP Common Data Model.
Partnerships
We conduct our work in close collaboration with healthcare institutions, academia, industry, medical societies and institutes across the globe.
Eureka Network
Leading SME on privacy preserving cross healthcare organization data analysis.
LATINO
Operational study partner of the Portuguese Society of Atherosclerosis for LATINO study.
Sigil Scientific Enterprises
SIGIL is our supplier of technology for RWE and IS implementation
Recent work
Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population
Health Outcomes in Women Victims of Intimate Partner Violence: A 20-Year Real-World Study
Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data
Safety Climate Evaluation in Primary Health Care: A Cross-Sectional Study
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study
Digital Health and Big Data Analytics: Implications of Real-World Evidence for Clinicians and Policymakers
Prosecutorial decision-making regarding offenders' social reintegration programs in intimate partner violence cases. A Portuguese study
20 Years of Real-World Data to Estimate the Prevalence of Heart Failure and Its Subtypes in an Unselected Population of Integrated Care Units
Premature Mortality in Type 2 Diabetes Mellitus Associated with Heart Failure and Chronic Kidney Disease: 20 Years of Real-World Data
Trauma outcomes in nonfatal road traffic accidents: a Portuguese medico-legal approach
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
Intimate partner violence against women. Does violence decrease after the entry of the alleged offender into the criminal justice system?
Suspension of Criminal Proceedings for Perpetrators of Intimate Partner Violence Against Women: Impact on Re-Entries
Cardiorenal syndrome and death risk in patients with heart failure or chronic kidney disease: an unmet cardiorenal need
Prevalence and characterization of heart failure in a population of integrated care users
HF and CKD present a dire prognosis in young Type 2 Diabetic patients
Cardiovascular risk profile in Portugal: evidence from a large population-based cohort
Contact us
Reach out to us for any enquires, applications, suggestions or ideas. All messages are very welcome. We usually respond within few minutes.